Detalhe da pesquisa
1.
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
N Engl J Med
; 388(18): 1645-1656, 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133584
2.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081848
3.
Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.
Ann Surg Oncol
; 29(13): 8016-8023, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900648
4.
Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
Breast Cancer Res Treat
; 185(1): 107-116, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32951084
5.
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.
Breast Cancer Res Treat
; 177(1): 103-114, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31134488
6.
Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a subanalysis of the ALTTO trial (BIG 206; NCCTG (Alliance) N063D).
Breast Cancer Res Treat
; 191(1): 225, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625860
7.
Ductal Carcinoma in Situ: Quantitative Preoperative Breast MR Imaging Features Associated with Recurrence after Treatment.
Radiology
; 285(3): 788-797, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28914599
8.
ASO Visual Abstract: Expanding Staging Criteria in T1-2N0 Hormone Receptor-Positive Breast Cancer Patients Enrolled in TAILORx.
Ann Surg Oncol
; 29(13): 8024-8025, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902504
9.
Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23.
Hum Mol Genet
; 22(13): 2748-53, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23462292
10.
Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?
Radiology
; 276(2): 371-80, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25965809
11.
Breast Cancer Risk Reduction, Version 2.2015.
J Natl Compr Canc Netw
; 13(7): 880-915, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26150582
12.
Predictors and outcomes of completion axillary node dissection among older breast cancer patients.
Ann Surg Oncol
; 21(7): 2172-80, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24585407
13.
Familial testicular germ cell tumor: no associated syndromic pattern identified.
Hered Cancer Clin Pract
; 12(1): 3, 2014 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24559313
14.
Timing and Reporting of Secondary Overall Survival End Points for Phase III Trials in Advanced/Metastatic Disease.
J Clin Oncol
; 41(29): 4616-4620, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37471685
15.
COVID-19 severity by vaccination status in the NCI COVID-19 and Cancer Patients Study (NCCAPS).
J Natl Cancer Inst
; 115(5): 597-600, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702472
16.
Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial.
JAMA Surg
; 158(6): 583-591, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043210
17.
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.
J Clin Oncol
; 41(27): 4433-4442, 2023 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433103
18.
The New NCI Precision Medicine Trials.
Clin Cancer Res
; 29(23): 4728-4732, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37531248
19.
Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour.
J Med Genet
; 48(7): 473-6, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21617256
20.
Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update.
J Clin Oncol
; 40(15): 1696-1698, 2022 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417251